Sex-specific cardiovascular drug dosages are needed to reduce adverse reactions in women

Sex-specific cardiovascular drug dosages are needed to reduce adverse reactions in women, according to a position paper from the European Society of Cardiology published in the European Heart Journal – Cardiovascular Pharmacotherapy. The position paper outlines the differences between women and men with respect to cardiovascular medications and gives recommendations on how to improve treatment in women. Key differences between women and men with respect to cardiovascular diseases and drugs:€¢    Women are at greater risk of cardiovascular disease than men because they live longer.€¢    Cardiovascular drug recommendations are based on clinical trials in middle-aged men.€¢    Adverse drug reactions are more severe